Kara Magane
Profiles

Kara Magane, MS

Senior Director of Research Operations, Health Law, Policy & Management - Boston University School of Public Health

(617) 358-1369
maganek@bu.edu
Talbot (T Bldg)
View Full Profile at BUMC

Biography

Kara Magane, MS, is Senior Director of Research Operations at the Boston University School of Public Health, where she manages a broad research portfolio spanning multiple departments on the BU Medical Campus. She supports the design, coordination, and implementation of large, complex, and multi-site studies, with a focus on building and sustaining research infrastructure and facilitating collaboration among investigators, teams, and external partners. Her work emphasizes operational efficiency, regulatory compliance, and research integrity.

She joined BU in 2019 following research roles at Boston Children’s Hospital and the University of Pennsylvania, where she contributed to studies focused on substance use and colorectal cancer screening. She holds a Master of Science in Health Promotion and a Bachelor of Arts in Sociology, magna cum laude, from the University of Delaware.

Her research contributions have been published in journals including JAMA Internal Medicine, Addiction Science & Clinical Practice, and Pediatrics, with a focus on substance use, HIV, and chronic disease.

Websites

Publications

  • Published on 6/9/2026

    Kim TW, Erlandson KM, Magane KM, Winter MR, Stein MD. Prevalence and clinical correlates of frailty among adults with HIV infection and unhealthy alcohol or drug use. AIDS. 2026 Jun 09. PMID: 42262480.

     Read At: PubMed
  • Published on 4/17/2026

    Cheng A, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Theisen J, Blakemore S, Saitz R, Bazzi AR. "The Sky Didn't Fall": Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion. J Addict Med. 2026 Apr 17. PMID: 41997587.

     Read At: PubMed
  • Published on 4/16/2026

    Weinstein ZM, Magane KM, Lodi S, Shea M, Chen CA, Doeleman D, Oot E, Bazzi AR, Davoust M, Ventura AS, Blakemore S, Saitz R. Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder. J Subst Use. 2026 Apr 16. PMID: 42326891.

     Read At: PubMed
  • Published on 1/5/2026

    Sheinin J, Brothers TD, Stein MD, Winter MR, Palfai TP, Magane KM, Bellamy S, Asbridge M, Kim TW. Cocaine Use, Unhealthy Alcohol Use, and Pain Interference Among People with HIV. AIDS Behav. 2026 Jan 05. PMID: 41491897.

     Read At: PubMed
  • Published on 10/29/2025

    Siebers R, Magane KM, Slayton H, Karzhevsky S, Palfai TP, Abrantes AM, Quintiliani LM, Stein MD. Lessons Learned Identifying and Controlling Fraudulent Participation in Online Randomized Trials. J Med Internet Res. 2025 Oct 29; 27:e77512. PMID: 41160082.

     Read At: PubMed
  • Published on 9/4/2025

    Weinstein ZM, Magane KM, Lodi S, Doeleman D, Ventura AS, Bazzi AR, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. Associations between COVID impact domains and time to buprenorphine treatment disengagement. Am J Drug Alcohol Abuse. 2025; 51(6):776-785. PMID: 40906491.

     Read At: PubMed
  • Published on 8/28/2025

    Theisen J, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Cheng A, Blakemore S, Blodgett J, Fielman S, Saitz R, Bazzi AR. Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment. Subst Use Addctn J. 2026 Jan; 47(1):144-152. PMID: 40876939.

     Read At: PubMed
  • Published on 7/23/2025

    Taghian NR, Palfai TP, Winter MR, Kim TW, Magane KM, Saitz R, Stein MD. Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support. Alcohol. 2025 Nov; 128:13-20. PMID: 40712846.

     Read At: PubMed
  • Published on 6/1/2025

    Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645. PMID: 40257810.

     Read At: PubMed
  • Published on 3/4/2025

    Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21. PMID: 40033433.

     Read At: PubMed

View 29 more publications:View Full Profile at BUMC

News & In the Media

View all profiles